You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of SP-A Derived Peptidomimetics for the Treatment of Asthma- Phase II
SBC: RaeSedo, LLC Topic: NHLBICurrent treatments for asthma, while reducing exacerbations in a subset of patients by focusing on airway inflammation, do not eliminate them. Asthma exacerbations are a significant cause of morbidity and mortality in asthma as they can lead to airway injury, lung function decline and death. Exacerbations in more severe asthmatics are of particular concern, as health care costs and lost productivi ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Critical angle reflection imaging for label-free quantification of molecular interactions
SBC: BIOSENSING INSTRUMENT INC Topic: 400TITLE: Critical angle reflection imaging (CARi) for label-free quantification of molecular interactions SUMMARYMeasuring molecular interactions of proteins are critical for understanding protein functions and cellular processes, for discovery and validating biomarkers, and for developing and screening drugs. In particular, membrane proteins play key roles in many cellular functions and are the lar ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Nanophotonic Optical Emulator for Complex Electromagnetic Maneuverability (EM) Systems
SBC: TIPD LLC Topic: N19AT008Develop an Optical Emulator of complex Electromagnetic Maneuverability (EM) systems with Nanophotonics structure.
STTR Phase II 2021 Department of DefenseNavy -
3-Band ps Pulse High Energy Compact Laser System for Marine Wave Boundary Layer Atmospheric Characterization Instrument Development
SBC: TIPD LLC Topic: N19AT009Gaining a deeper experimental and theoretical understanding of maritime turbulence and laser light propagation in the marine boundary is required to optimize the performance of critical communication and defensive and offensive laser light engagements. Increased understanding of beam propagation through the turbulent flows of the marine layer will help the US Navy improve the performance of beam o ...
STTR Phase II 2021 Department of DefenseNavy -
High Efficiency Ceramic Propeller for Small UAS
SBC: HYDRONALIX INC Topic: N20AT006The purpose of this program is to develop and demonstrate “CerFoil”, a radically new lightweight ceramic/composite propeller for use in small-unmanned air systems (SUAS). In the Phase I program, Hydronalix and Oklahoma State University team proved the concept of a high-strength high modulus propeller and tested the same showing potential for increased duration. The Hydronalix/OSU team will con ...
STTR Phase II 2021 Department of DefenseNavy -
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
SBC: AQUALUNG THERAPEUTICS, CORP Topic: NHLBIABSTRACT The development of radiation-induced lung injury (RILI) is a potentially fatal toxicity in cancer patients undergoing thoracic radiotherapy or in individuals exposed to ionizing radiation (IR) from a nuclear incident. The pathobiology of radiation pneumonitis and radiation-induced lung fibrosis (RILF) is complex but includes the deleterious effects of unchecked inflammation (reactive oxyg ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
SBC: Faknostics, LLC Topic: 102Abstract Melanoma is the deadliest form of skin cancer, affecting an estimated 1.2 million Americans. The disease has a high propensity for dissemination, and metastatic melanoma has a dismal prognosis, with a median survival of only 5–8 months. Healthcare costs for melanoma in 2021 are projected to reach nearly $4 billion, with a rising incidence rate. Despite considerable efforts in recent yea ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Marine Atmospheric Modeling, Data Collection, Visualization & Metrological Toolset for Submarine Electromagnetic (EM) Maneuverability
SBC: N.P. PHOTONICS, INC. Topic: N19AT015Develop an electromagnetic (EM) beam propagation prediction toolset that combines the metrological Marine Wave Boundary Layer (MWBL) atmospheric model, the short pulse multi-band metrological toolset, and visualization software/hardware and uses compact single-aperture Light i detection and ranging (LIDAR) technology for estimating beam performance in the MWBL.
STTR Phase II 2021 Department of DefenseNavy -
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: ODAbstract Duchenne Muscular Dystrophy (DMD) is a fatal muscle disease with a predicted incidence of 1 in 5000 males. DMD results from mutations in the gene encoding dystrophin, a 427 kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and laminin in the extracellular matrix. The 7β1 integrin is a transmembrane linkage system in skeleta ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)
SBC: AQUALUNG THERAPEUTICS, CORP Topic: NHLBIMortality rates in intensive care units (ICUs) are unacceptably high and are directly related to the duration of mechanical ventilation that is required to support patients with respiratory failure. For example, acute respiratory distress syndrome (ARDS) is a vexing acute inflammatory lung disease requiring mechanical ventilatory support as the result of severe hypoxemia and respiratory failure. T ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health